Sign Out
Hypersensitivity to cyclosporine, or any component of the products.
Rheumatoid arthritis or psoriasis patients with abnormal renal function, uncontrolled hypertension, or malignancies.
The risk of developing malignancies of the skin and lymphoproliferative disorders is increased in patients receiving cyclosporine concurrently with PUVA or UVB, methotrexate or other immunosuppressive agents, coal tar or radiation therapy in psoriasis patients.
